Olanzapine
Product Images NDC 53002-2505

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 53002-2505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022505)

Olanzapine 5mg tablets packaging label from RPK Pharmaceuticals, Inc. showing a 30-tablet bottle with directions stating to take one tablet daily as directed. The label includes dosage instructions, lot number, expiration date, and placeholders for clinic name and patient information.*

FDA Label Image

Image Description (Olanzapine Str)

Chemical structure diagram of olanzapine, displaying its molecular framework including a benzodiazepine ring fused with a thiophene and various nitrogen-containing groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.